# Carlos Pavésio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carlos-pavesio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,754 |
| Field | Ocular Diseases and Behçet’s Syndrome |
| h-index | 54 |
| i10-index | 181 |
| Last Known Institution | Moorfields Eye Hospital NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5012009183 |
| ORCID iD | 0000-0002-1625-2777 |
| Works | 385 |

## Researcher papers

- [Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/adalimumab-for-prevention-of-uveitic-flare-in-patients-with-inactive-non/)
- [Choroidal Vascularity Index (CVI) - A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis?](https://scholariq.org/papers/choroidal-vascularity-index-cvi-a-novel-optical-coherence-tomography-parameter/)
- [Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique](https://scholariq.org/papers/assessment-of-red-blood-cell-deformability-in-type-2-diabetes-mellitus-and/)
- [Ocular Adverse Events After COVID-19 Vaccination](https://scholariq.org/papers/ocular-adverse-events-after-covid-19-vaccination/)
- [Macular edema](https://scholariq.org/papers/macular-edema/)
- [Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)–1](https://scholariq.org/papers/clinical-features-and-outcomes-of-patients-with-tubercular-uveitis-treated-with/)
- [Acute Retinal Necrosis](https://scholariq.org/papers/acute-retinal-necrosis/)
- [New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review](https://scholariq.org/papers/new-observations-and-emerging-ideas-in-diagnosis-and-management-of-non/)
- [Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production](https://scholariq.org/papers/rituximab-is-effective-in-the-treatment-of-refractory-churg-strauss-syndrome-and/)
- [Evaluation of an Intravitreal Fluocinolone Acetonide Implant versus Standard Systemic Therapy in Noninfectious Posterior Uveitis](https://scholariq.org/papers/evaluation-of-an-intravitreal-fluocinolone-acetonide-implant-versus-standard/)
- [Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-Induced Anterior Uveitis: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/antiviral-therapy-for-varicella-zoster-virus-vzv-and-herpes-simplex-virus-hsv/)

## Researcher topics

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Retinal and Optic Conditions](https://scholariq.org/topics/retinal-and-optic-conditions/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ocular Infections and Treatments](https://scholariq.org/topics/ocular-infections-and-treatments/)
- [Infectious Diseases and Tuberculosis](https://scholariq.org/topics/infectious-diseases-and-tuberculosis/)

## Researcher university

- [Moorfields Eye Hospital NHS Foundation Trust](https://scholariq.org/institutions/moorfields-eye-hospital-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
